Literature DB >> 14971642

Arsenite induces p70S6K1 activation and HIF-1alpha expression in prostate cancer cells.

Heath D Skinner1, Xiao-song Zhong, Ning Gao, Xianglin Shi, Bing-Hua Jiang.   

Abstract

Arsenite is ubiquitous in the environment, particularly in the form of contaminated water. Although this metal is a known human carcinogen, its exact mechanism of action remains unclear. P70S6K1 phosphorylates the ribosomal 40S protein leading to increased protein translation, and is an important regulator of cell growth and proliferation. Hypoxia inducible factor-1 (HIF-1) is a basic helix-loop-helix transcription factor composed of two subunits, HIF-1alpha and HIF-1beta. HIF-1 activates the transcription of a number of genes that mediate angiogenesis and tumor formation. In this study we demonstrated that arsenite treatment increased levels of p70S6K1 phosphorylation and p70S6K1 activity in a PI3K and mTOR sensitive manner. We have also shown that arsenite specifically induces HIF-1alpha, but not HIF-1beta, protein levels in prostate cancer cells in a mTOR-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14971642     DOI: 10.1023/b:mcbi.0000007257.67733.3b

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

1.  PI 3-kinase, mTOR, protein synthesis and cancer.

Authors:  P K Vogt
Journal:  Trends Mol Med       Date:  2001-11       Impact factor: 11.951

Review 2.  Resistance to rapamycin: a novel anticancer drug.

Authors:  S Huang; P J Houghton
Journal:  Cancer Metastasis Rev       Date:  2001       Impact factor: 9.264

3.  Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite.

Authors:  M C Duyndam; T M Hulscher; D Fontijn; H M Pinedo; E Boven
Journal:  J Biol Chem       Date:  2001-10-18       Impact factor: 5.157

4.  Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.

Authors:  H Zhong; K Chiles; D Feldser; E Laughner; C Hanrahan; M M Georgescu; J W Simons; G L Semenza
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

5.  Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.

Authors:  B H Jiang; G Jiang; J Z Zheng; Z Lu; T Hunter; P K Vogt
Journal:  Cell Growth Differ       Date:  2001-07

6.  V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.

Authors:  B H Jiang; F Agani; A Passaniti; G L Semenza
Journal:  Cancer Res       Date:  1997-12-01       Impact factor: 12.701

7.  3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro.

Authors:  D R Alessi; M T Kozlowski; Q P Weng; N Morrice; J Avruch
Journal:  Curr Biol       Date:  1998-01-15       Impact factor: 10.834

8.  Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species.

Authors:  Ning Gao; Min Ding; Jenny Z Zheng; Zhuo Zhang; Stephen S Leonard; Ke Jian Liu; Xianglin Shi; Bing-Hua Jiang
Journal:  J Biol Chem       Date:  2002-06-17       Impact factor: 5.157

Review 9.  Arsenic-mediated cellular signal transduction, transcription factor activation, and aberrant gene expression: implications in carcinogenesis.

Authors:  Chengfeng Yang; Krystyna Frenkel
Journal:  J Environ Pathol Toxicol Oncol       Date:  2002       Impact factor: 3.567

Review 10.  Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

Authors:  P R Shepherd; D J Withers; K Siddle
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

View more
  8 in total

1.  Activation and up-regulation of translation initiation factor 4B contribute to arsenic-induced transformation.

Authors:  Yong Zhang; Qing Wang; Xiaoling Guo; Robert Miller; Yinglu Guo; Hsin-Sheng Yang
Journal:  Mol Carcinog       Date:  2011-01-25       Impact factor: 4.784

2.  Effects of 12 metal ions on iron regulatory protein 1 (IRP-1) and hypoxia-inducible factor-1 alpha (HIF-1alpha) and HIF-regulated genes.

Authors:  Qin Li; Haobin Chen; Xi Huang; Max Costa
Journal:  Toxicol Appl Pharmacol       Date:  2006-01-04       Impact factor: 4.219

3.  Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus.

Authors:  Armina A Kazi; Kristin Happ Molitoris; Robert D Koos
Journal:  Biol Reprod       Date:  2009-05-06       Impact factor: 4.285

Review 4.  Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment.

Authors:  Bing-Hua Jiang; Ling-Zhi Liu
Journal:  Drug Resist Updat       Date:  2008-04-28       Impact factor: 18.500

5.  Role and mechanism of arsenic in regulating angiogenesis.

Authors:  Ling-Zhi Liu; Yue Jiang; Richard L Carpenter; Yi Jing; Stephen C Peiper; Bing-Hua Jiang
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

6.  Upregulation of CENPM facilitates tumor metastasis via the mTOR/p70S6K signaling pathway in pancreatic cancer.

Authors:  Chenlei Zheng; Tan Zhang; Ding Li; Chongchu Huang; Hengjie Tang; Xiao-Feng Ni; Bicheng Chen
Journal:  Oncol Rep       Date:  2020-07-07       Impact factor: 3.906

Review 7.  Hypoxia-Inducible Factors (HIFs) and Phosphorylation: Impact on Stability, Localization, and Transactivity.

Authors:  Thomas Kietzmann; Daniela Mennerich; Elitsa Y Dimova
Journal:  Front Cell Dev Biol       Date:  2016-02-23

Review 8.  PI3K/Akt/mTOR Signaling Pathway and the Biphasic Effect of Arsenic in Carcinogenesis.

Authors:  Qiao Yi Chen; Max Costa
Journal:  Mol Pharmacol       Date:  2018-05-16       Impact factor: 4.436

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.